PRFX Company Profile and Key Details

PRFX has shown mixed momentum, gaining 21.7% over the past week and -21.21% over the past quarter, though year-to-date performance is up 52.23%. Short-term trend indicators are bullishly aligned (SMA20 0.89%, SMA50 -14.77%, SMA200 -48.96%). The stock’s 14-day RSI is 46.18 (neutral), while the ATR of 0.46 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -82.17% below its high and over 24.51% above its low. Average 10-day trading volume of 16.89 thousand shares is below the 3-month average of 550.46 thousand, indicating normal recent market interest.

PRF Technologies Ltd. has 2.01 million shares outstanding. The public float is 1.34 million shares, elevated short interest at 7.02% of float. This equals 111.85 thousand shares. The short ratio is 0.84 days. Institutional investors hold 3.46% of the float. Insiders own 9.62%.

PRF Technologies Ltd. generated EPS of $nan over the past year. Five-year average earnings growth is 12.33%. The latest quarter delivered EPS of -$18.96. The next quarter is forecast at $nan. Next year's EPS is expected at $28.28. PRF Technologies Ltd. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 19, 2024, missed forecasts by 300.0%. The prior quarter beat by 300.0%. Over the last six quarters, Apple has recorded several small beats. These include 108.72% in March 01, 2024.

PRF Technologies Ltd. (NASDAQ:PRFX) closed at $1.61 USD, gaining $0.10 (6.62%) from the previous close of $1.51. The stock is currently mid-range between its 52-week high and low $1.41 and $17.95. With a market capitalization of about $129.66 thousand, PRF Technologies Ltd. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.77). Key stats such as the average daily volume over the past year has been around 517.66 thousand shares, volume is running light vs its 52-week average. Headquartered in Tel Aviv, None, PRF Technologies Ltd. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Efraim Cohen-Arazi, the company employs approximately 2 people and listed since September 01, 2020. PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel.

PRF Technologies Ltd. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $6.42. This means the shares are trading below this model’s fair value.

PRF Technologies Ltd. trades at a P/E ratio of -0.04, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 0.02 suggesting the stock is closer to book value. The P/FCF stands at -0.03, also below market averages.

PRF Technologies Ltd. (NASDAQ:PRFX) shares are up 52.23% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows PRF Technologies Ltd. trading at a premium to the broader market with a P/E of -0.04. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $2.00, suggesting 24.22% upside. Our AI forecast model points to short-term weakness (-19.25% over two weeks), a medium-term fall (-65.84% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that PRF Technologies Ltd. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -19.25%, with price expected at $1.30 by June 02, 2026, within a range of $0.95 to $1.68 3-Month Outlook: Projected fall of -65.84%, reaching $0.55 by August 17, 2026, with a range of $0.00 to $1.69. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by May 19, 2027, within a range of $0.00 to $17.95.